table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID-19 prophylaxis (excluding children)
Sinopharm Beijing (BBIBP-CorV) Xia ... Kanokudom

3 studies excluded by filtering options 1

9216 Sultan, 2022 0120selection pending
9463 Ashmawy, 2022 1110not a RCTrisk of bias not avaialble
9614 Rearte, 2022 0120selection pending

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons